Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms. Blood. 2022.
N6-methyladenosine promotes induction of ADAR1-mediated A-to-I RNA editing to suppress aberrant antiviral innate immune responses. PLoS Biol. 2021;19(7):e3001292..
Stabilization of ERK-Phosphorylated METTL3 by USP5 Increases mA Methylation. Mol Cell. 2020;80(4):633-647.e7.